Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.49 |
| ▸ | KDM1A | O60341 | 1/20 | 0.49 |
| ▸ | USP30 | Q70CQ3 | 5/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 3/20 | 0.45 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.44 |
| ▸ | CASP3 | P42574 | 3/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2905961 | 1.00 | CTSL (0.52) | CTSLHDAC1KDM1AUSP30ALDH1A1 | |
| SCHEMBL2905546 | 0.88 | CTSL (0.60) | CTSLHDAC1USP30ALDH1A1MAPT | |
| SCHEMBL2905549 | 0.88 | CTSL (0.60) | CTSLHDAC1USP30ALDH1A1MAPT | |
| SCHEMBL2903093 | 0.84 | CTSL (0.53) | CTSLHDAC1ALDH1A1MAPTMAPK1 | |
| SCHEMBL2903098 | 0.84 | CTSL (0.53) | CTSLHDAC1ALDH1A1MAPTMAPK1 | |
| SCHEMBL2905746 | 0.84 | CTSL (0.53) | CTSLHDAC1ALDH1A1MAPTMAPK1 | |
| SCHEMBL2905530 | 0.81 | USP30 (0.50) | CTSLHDAC1USP30MAPTHDAC3 | |
| SCHEMBL2905526 | 0.81 | USP30 (0.50) | CTSLHDAC1USP30MAPTHDAC3 | |
| SCHEMBL2909283 | 0.74 | HDAC8 (0.53) | HDAC1MAPTHDAC3HDAC8HDAC6 | |
| SCHEMBL2905625 | 0.73 | HDAC8 (0.62) | CTSLHDAC1USP30HDAC3HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1763507-B1 | ALPHA-AMINO ACID DERIVATES WITH ANTIINFLAMMATORY ACTIVITY | ITALFARMACO SPA (IT) | 2010-08-11 | — | — | EP | claimed |
| US-7635788-B2 | Alpha-amino acid derivatives with antiinflammatory activity | ITALFARMACO SPA (IT) | 2009-12-22 | — | — | US | claimed |
| US-20080076807-A1 | Alpha-Amino Acid Derivatives with Antiinflammatory Activity | ITALFARMACO SPA (IT) | 2008-03-27 | — | — | US | claimed |
| EP-1763507-B1 | ALPHA-AMINO ACID DERIVATES WITH ANTIINFLAMMATORY ACTIVITY | ITALFARMACO SPA (IT) | 2010-08-11 | — | — | EP | disclosed |
| US-7635788-B2 | Alpha-amino acid derivatives with antiinflammatory activity | ITALFARMACO SPA (IT) | 2009-12-22 | — | — | US | disclosed |
| US-20080076807-A1 | Alpha-Amino Acid Derivatives with Antiinflammatory Activity | ITALFARMACO SPA (IT) | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076807-A1 | Alpha-Amino Acid Derivatives with Antiinflammatory Activity | TNF, NFKBIA, IFNG | CTSL 321/4885HDAC1 3360/4885KDM1A 3101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.